A Mab A Case Study In Bioprocess Development !link! • Pro
A Mab reached the clinic in 28 months from transfection – 6 months ahead of schedule. Today, it’s a blockbuster therapy. But the bioprocess continues to evolve. The team is now implementing (perfused N-1 and connected capture) to boost productivity to 15 g/L and reduce COGS by 40%.
This case study demonstrates:
A-Mab Case Study a landmark industry document that demonstrates how Quality by Design (QbD) A Mab A Case Study In Bioprocess Development
A Mab reached the clinic in 28 months from transfection – 6 months ahead of schedule. Today, it’s a blockbuster therapy. But the bioprocess continues to evolve. The team is now implementing (perfused N-1 and connected capture) to boost productivity to 15 g/L and reduce COGS by 40%.
This case study demonstrates:
A-Mab Case Study a landmark industry document that demonstrates how Quality by Design (QbD)